Design, Synthesis, and Biological Evaluation of Benzo[B]Thiophene 1,1-Dioxide (BTP) Derivatives
Li Ding,Xuedong Li,Wenying Yan,Xingang Liu,Fang Deng,Xiaoling Chen,Yang Zhang,Qingzhong Jia,Deyan He
DOI: https://doi.org/10.2139/ssrn.4565703
2023-01-01
Abstract:Colorectal cancer (CRC) is one of the most common malignancies, and its pathogenesis is closely related to the abnormally activated JAK/STAT3 signaling pathway. In this study, based on molecular fusion strategy, 36 target compounds were designed and synthesized by introducing effective fragments of non-steroidal anti-inflammatory drugs (NSAIDs) into the core structure of benzo[b]thiophene 1,1-dioxide (BTP). Through the evaluation of anti-proliferation activity, the synthesized compounds exhibited promising anti-tumor proliferative activity (IC50: 1~10 μM), and the apoptosis mechanism of representative compounds a1-2 and a1-5 were further explored via cycle arrest, assessment of reactive oxygen species (ROS) level, measurement of mitochondrial membrane potential, detection of apoptosis-related protein expression, and so on. The representative compounds a1-2 and a1-5 could trigger the accumulation of ROS, and reduce the mitochondrial membrane potential, leading to the mitochondrial dysfunction. In addition, compounds a1-2 and a1-5 could also activate caspase-3 by regulating the expression of apoptotic proteins, such as Bax and Bcl-2, promoting the apoptosis of tumor cells. More importantly, a1-2 and a1-5 could reduce the expression levels of the phosphorylated JAK2 and STAT3, deactivating the JAK/STAT3 signaling pathway, further verifying the rationality of the compound design. In sum, compounds a1-2 and a1-5 could exert significant anti-proliferative activities by influencing the mitochondrial functions, regulating the expression of apoptotic proteins, and reducing the phosphorylation expression levels of JAK2 and STAT3, providing valuable hints for the subsequent discovery of anti-colorectal cancer drugs.